The Combination of Metformin and Disulfiram-Cu for Effective Radiosensitization on Glioblastoma Cells
Objective: Glioblastoma (GBM) is one of the devastating types of primary brain tumors with a negligible response to standard therapy. Repurposing drugs, such as disulfiram (DSF) and metformin (Met) have shown antitumor properties in different cell lines, including GBM. In the present study, we foc...
Main Authors: | Narges Rezaei, Ali Neshasteh-Riz, Zohreh Mazaheri, Fereshteh Koosha, Mahmood Hoormand |
---|---|
Format: | Article |
Language: | English |
Published: |
Royan Institute (ACECR), Tehran
2020-10-01
|
Series: | Cell Journal |
Subjects: | |
Online Access: | https://celljournal.org/journal/article/abstract/6798 |
Similar Items
-
Disulfiram and metformin combination anticancer effect reversible partly by antioxidant nitroglycerin and completely by NF-κB activator mebendazole in hamster fibrosarcoma
by: Kosta J. Popović, et al.
Published: (2021-11-01) -
Disulfiram, a Ferroptosis Inducer, Triggers Lysosomal Membrane Permeabilization by Up-Regulating ROS in Glioblastoma
by: Qiu C, et al.
Published: (2020-10-01) -
Disulfiram reaction
by: Banjac Nada, et al.
Published: (2019-01-01) -
Disulfiram-like reaction with ornidazole
by: Sharma V, et al.
Published: (2009-01-01) -
Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
by: Vinodh Kannappan, et al.
Published: (2021-09-01)